Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2008;336:1033 (10 May), doi:10.1136/bmj.39568.466910.80
| The first 150 words of the full text of this article appear below. |
I find the debate about sentinel node biopsy puzzling.1 Clinicians are getting bogged down with this question while the fundamentals of managing cutaneous melanoma are being neglected. A recent Australian study showed that doctors perform poorly in key aspects of managing this aggressive tumour.2 Only a third of doctors excised cutaneous melanoma with the margins recommended by the Australian guidelines—a third used larger margins and, more worrying, a third used narrower margins. Most doctors failed to check the skin at follow-up, and they often diagnosed suspicious lesions by biopsy not local excision. Australian surgeons are slow to acquire dermoscopic skills that improve early diagnosis of melanoma. A patient with a thin melanoma is more likely to develop another cutaneous primary than metastatic disease. Yet dermoscopy and skin checks are often neglected.
If surgeons used time spent doing sentinel lymph node biopsy in routinely examining the skin at follow-up, there would
Anthony Dixon, censor
1 Australasian College of Skin Cancer Medicine, Geelong, VIC 3216, Australia
anthony@skincanceronly.com